8 Results for "

Hyperphosphorylated

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "Hyperphosphorylated" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-130795
CAS No.: 1702428-31-6
Purity:  97.68%
Target:  

GSK-3

Research Areas:  

Neurological Disease

GSK-3β inhibitor 2 (Compound 3) is a potent, selective and orally active GSK-3β inhibitor with an IC50 of 1.1 nM. GSK-3β inhibitor 2 can cross the blood-brain barrier. GSK-3β inhibitor 2 has the potential for Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-162566
CAS No.: 1417823-67-6
REM127 is an orally active, blood-brain barrier-penetrant septin 6/7 molecular glue degrader. REM127 binds to SEPT6 with high affinity and promotes the assembly of SEPT2/6/7 cortical filaments, thereby normalizing cytoplasmic calcium levels, cerebrospinal fluid hyperphosphorylated tau protein levels, synaptic function and cognitive function. REM127 can be used in research related to Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-174311
CAS No.: 2648407-76-3
Target:  

Glycosidase

GT-02216 can bind to GCase allosterically and enhance its activity. GT-02216 enhances the activity of GCase in primary human fibroblasts dose-dependently reduces the accumulation of its substrate, hexosylsphingosine (HexCer). GT-02216 reduces the Tau accumulation in mutant GBA1 fibroblasts. GT-02216 can be used for the study of Parkinson’s disease .
loading...
    loading...
Cat. No.: HY-159083
CAS No.: 937012-09-4
Purity:  99.01%
Target:  

Amyloid-β

Research Areas:  

Neurological Disease

DN5355 is a small molecule compound that targets amyloid β protein () and hyperphosphorylated tau protein. DN5355 can inhibit the aggregation of and tau protein and disaggregate the formed and tau protein fibers. DN5355 can be used in the study of Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-161458
Target:  

GSK-3 Tau Protein

Research Areas:  

Neurological Disease

GSK-3β inhibitor 16 (compound 7c) is a GSK-3β inhibitor with the IC50 of 4.68 nM. GSK-3β inhibitor 16 decreases Tau hyperphosphorylated aggregate and alleviates cognitive impairments in the Scopolamin (HY-N0296)-induced model in mice .
loading...
    loading...
Cat. No.: HY-162860
CAS No.: 1030759-58-0
Target:  

mGluR CaMK Tau Protein

Research Areas:  

Neurological Disease

FO-4-15 is an mGluR1/CaMKIIα activator. FO-4-15 has a protective effect against H2O2 in human neuroblastoma (SH-SY5Y) cells. FO-4-15 can improve cognitive impairment in Alzheimer’s disease mice by activating the mGluR1/CaMKIIα pathway, and can reduce accumulation, hyperphosphorylated Tau, and synaptic damage .
loading...
    loading...
Cat. No.: HY-183375
Research Areas:  

Neurological Disease

AChE/BuChE/BACE-1-IN-1 is a blood-brain barrier-permeable multi-target inhibitor of AChE/BuChE/BACE, with IC50 values of 0.387 μM, 0.430 μM, and 0.531 μM against AChE, BuChE, and BACE-1, respectively. AChE/BuChE/BACE-1-IN-1 reduces the aggregation of β-amyloid protein () and hyperphosphorylated tau protein (p-tau). AChE/BuChE/BACE-1-IN-1 can be used for the research of Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-182447
CAS No.: 69095-83-6
Synonyms: DL111-IT
Target:  

CDK Apoptosis

Research Areas:  

Endocrinology Cancer

Contragestazol (DL111-IT) is a non-hormonal antifertility agent. Contragestazol reduces the expression of Cyclin D1 and CDK4, increases the expression of total retinoblastoma protein (pRb), and decreases the level of hyperphosphorylated pRb. Contragestazol induces G0/G1 phase cell cycle arrest. Contragestazol inhibits embryonic development by inducing luteal cell apoptosis and reducing intrauterine polyamine levels. Contragestazol exhibits antitumor activity against prostate cancer, S180 tumor and H22 tumor. Contragestazol shows extremely potent activity in terminating early pregnancy in animals .
loading...
    loading...